A longitudinal population study of climacteric symptoms and their treatment in a random sample of Swedish women

Climacteric

Volumn 7, Issue 4, 2004, Pages 357-365

  Thunell, L ^a,b   Stadberg, E ^a   Milsom, I ^a   Mattsson, L A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body mass; Climacteric symptoms; Epidemiology; Exercise; Hormone replacement therapy; Menopause

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRIOL; ESTROGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTHRALGIA; ARTICLE; BODY WEIGHT; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; DRUG POTENCY; EXERCISE; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; IRRITABILITY; LIBIDO DISORDER; MENOPAUSAL SYNDROME; MYALGIA; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTIVE HEALTH; SLEEP DISORDER; SMOKING; SWEDEN; TREATMENT OUTCOME; VASOMOTOR DISORDER;

AGE DISTRIBUTION; BODY MASS INDEX; CLIMACTERIC; DEPRESSION; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; HEALTH BEHAVIOR; HUMANS; IRRITABLE MOOD; JOINTS; LIBIDO; LONGITUDINAL STUDIES; MIDDLE AGED; MUSCLE, SKELETAL; PAIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; SMOKING; SWEDEN; VASOMOTOR SYSTEM;

EID: 10944228193     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130400001786     Document Type: Article

References (36)

1. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103-15
2. Hammar M, Berg G, Fahraeus L, Larsson-Cohn U. Climacteric symptoms in an unselected sample of Swedish women. Maturitas 1984;6:345-50
3. Hagstad A, Janson PO. The epidemiology of climacteric symptoms. Acta Obstet Gynecol Scand Suppl 1986;134:59-65
4. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977;4:31-47
5. Stadberg E, Mattsson LA, Milsom I. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population. Acta Obstet Gynecol Scand 1997;76:442-8
6. Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study. Menopause 2000;7:273-81
7. Holte A. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas 1992;14:127-41
8. Kaufert PA, Gilbert P, Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas 1992;14:143-55
9. Collins A, Landgren BM. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study. Maturitas 1994;20:101-11
10. Stadberg E, Mattsson LA, Milsom I. Women's attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study. Maturitas 1997;27:109-16
11. Backe B, Hunskaar S. Increased acceptance of HRT and improved level of information: a change in Norwegian women's opinion from 1990 to 1997. Acta Obstet Gynecol Scand 2001;80:623-7
12. Andersson K, Mattsson LA, Milsom I. Use of hormone replacement therapy. Lancet 1996;348:1521
13. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33
14. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. Heart and Estrogen/ progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605-13
15. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59
16. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27
17. Bakken K, Eggen AE, Lund E. Hormone replacement therapy in Norwegian women, 1996-1997. Maturitas 2001;40:131-41
18. Vihtamaki T, Savilahti R, Tuimala R. Why do postmenopausal women discontinue hormone replacement therapy? Maturitas 1999;33:99-105
19. MacLennan AH, Wilson DH, Taylor AW. Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion. Climacteric 1998;1:42-9
20. Newton KM, LaCroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. Women's beliefs and decisions about hormone replacement therapy. J Women's Health 1997;6:459-65
21. Nagata C, Matsushita Y, Shimizu H. Prevalence of hormone replacement therapy and user's characteristics: a community survey in Japan. Maturitas 1996;25:201-7
22. Collins A, Landgren BM. Psychosocial factors associated with the use of hormonal replacement therapy in a longitudinal follow-up of Swedish women. Maturitas 1997;28:1-9
23. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-62
24. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-50
25. Castellsague J, Perez Gutthann S, Garcia Rodriguez LA. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review. Drug Saf 1998;18:117-23
26. Estrogen use continues to decrease. In Third Quarter Report on National Drug Use (Swedish). Stockholm: The National Board of Health and Welfare, 2002. http://www.sos.se/FULLTEXT/125/2002-125-18/2002-125-18.htm.
27. Noppa H, Andersson M, Bengtsson C, Bruce A, Isaksson B. Longitudinal studies of anthropometric data and body composition. The population study of women in Gotenberg, Sweden. Am J Clin Nutr 1980;33:155-62
28. Lissner L, Johansson SE, Qvist J, Rossner S, Wolk A. Social mapping of the obesity epidemic in Sweden. Int J Obes Relat Metab Disord 2000;24:801-5
29. Dey DK, Rothenberg E, Sundh V, Bosaeus I, Steen B. Height and body weight in the elderly. I. A 25-year longitudinal study of a population aged 70 to 95 years. Eur J Clin Nutr 1999;53:905-14
30. Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 1997;82:1549-56
31. Bardel A, Wallander MA, Svardsudd K. Hormone replacement therapy and symptom reporting in menopausal women: a population-based study of 35-65-year-old women in mid-Sweden. Maturitas 2002;41:7-15
32. Ekstrom H, Hovelius B. Quality of life and hormone therapy in women before and after menopause. Scand J Prim Health Care 2000;18:115-21
33. Skarsgard C, Berg G, Ekblad S, Wiklund I, Hammar ML. Effects of estrogen therapy on well-being in postmenopausal women without vasomotor complaints. Maturitas 2000;36:123-30
34. Karlberg J, Mattsson LA, Wiklund I. A quality of life perspective on who benefits from estradiol replacement therapy. Acta Obstet Gynecol Scand 1995;74:367-72
35. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824-30
36. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/progestin Replacement Study (HERS) trial. J Am Med Assoc 2002;287:591-7